Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction

NCT03105518 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-08-03

Study results available
· View outcomes & findings →

Summary

The central objective of this study will be to evaluate the relationship between estrogen levels and the pain following oocyte retrieval in women undergoing in vitro fertilization.

Conditions

  • Oocyte Retrieval
  • Postoperative Pain

Interventions

DRUG

Fentanyl

0.5, 1 mcg/kg

DRUG

Acetaminophen

Single + Oxycodone

DRUG

Oxycodone

With Acetaminophen

Sponsors & Collaborators

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Lawrence C Tsen, MD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-01
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03105518 on ClinicalTrials.gov